Genmab | GEN - Current Assets



Genmab reported DKK3.91B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Agios Pharmaceuticals USD 1.02B 50.85M Jun/2025
Almirall EUR 714.05M 50.55M Jun/2025
Amarin USD 573.06M 22.34M Mar/2025
Amgen USD 26.73B 195M Jun/2025
argenx SE 5.83B 946.64M Jun/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
BioMarin Pharmaceutical USD 3.81B 337.43M Jun/2025
Demant DKK 10.2B 282M Jun/2025
Exelixis USD 1.18B 215.74M Jul/2025
Fresenius Medical Care EUR 8.14B 178.09M Jun/2025
Galapagos EUR 3.26B 217.04M Jun/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
GN Store Nord DKK 8.99B 105M Jun/2025
GRIFOLS EUR 5.25B 393.8M Jun/2025
Hikma Pharmaceutical USD 2.26B 22M Dec/2024
Insmed USD 2.08B 678.89M Jun/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.2B 216M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Regeneron Pharmaceuticals USD 16.86B 712.2M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025
UCB EUR 4.79B 1.47B Dec/2024